SABI Mind

The artful mending of pain and mental health through psychedelic assisted therapies.

[The Emergent Phenomenology Research Consortium @the_emergent]

Challenging Psychedelic Experiences Project @psychedelicrisk, supported in part by the EPRC, is hosting a free Psychedelic Safety Seminar on Thursday online at 5pm UK/ 12 EST / 9am PST w/ Philippe Lucas (@SabiMind) @JulesEvans11 @d_mathai https://t.co/4JxeT1HoDB #psychedelics

[FRAME @Framepublishers]

For @SabiMind, a holistic psychedelic-assisted psychotherapy centre in Alberta, Solo Studio turned to homelike aesthetics to assuage unease and anxiety. The design fuses the Japanese philosophy of wabi-sabi (beauty in imperfection and impermanence).
https://t.co/xlRL7ija1C

[PSYCSpotlight @PSYC_Spot]

.@sabimind Releases Global Psychedelic #Survey

Adults around the world with direct experiences with #psychedelics can participate in the historic Global Psychedelic Survey and help shape the future of psychedelic research and policy.

https://t.co/OPX16szvK4

[Mind Medicine Australia @MindMedicineAU]

2/2 The survey will only be available online from May 19th - June 2nd, 2023. Take the survey and enter to win the giveaway: https://t.co/JWl3d723fv @MAPS @SabiMind @mindmedicineAU

[Dr. Eric P. Baron @Neuralgroover]

PLEASE RT, we need YOUR help!!! Have YOU ever used #Psychedelics for ANY reason (medical, recreational, etc.)??

We are excited to announce the launch of the Global Psychedelic Survey (GPS). English-speaking adults 21+ from around the globe have the opportunity to participate in the most comprehensive assessment of global psychedelic use amongst adults to date.

We believe that the primary experts on psychedelic substances are the consumers, and sharing your lived experience could help reduce stigma and inform policy decisions impacting safe, legal access for both medical and non-medical use.

Participants will have an opportunity to be entered into a drawing for 1 of 3 $500 USD Amazon gift certificates.

The survey will ONLY be available online from May 19th - June 2nd, 2023.

Click the link to take the survey and enter to win the giveaway:
https://t.co/O9eRrs7dw0

Co-sponsored by SABI Mind, Multidisciplinary Association of Psychedelic Studies (MAPS), Mind Medicine Australia, and Tiny. @MAPS @SabiMind @mindmedicineAU

This survey is all-inclusive, collecting data for ALL reasons of use for ALL forms of psychedelics including #Psilocybin #MagicMushrooms #Shrooms #Mushrooms #LSD #Acid #LSDtrip #AcidTrip #DMT #DMTtrip #5Meo 5-Meo #5MeoDMT 5-Meo-DMT #Ketamine #Khole #MDMA #MDA #Molly #Ecstasy #Mescaline #Peyote #SanPedro #Ayahuasca #Iboga #Ibogaine #2CB 2C-B #SalviaDivinorum #Salvia #NitrousOxide #Whippits and others.

We need YOUR participation to help advance the science, legitimacy, and policy making of psychedelic use!

There are many researchers who have infused questions into the survey, including myself. I’ll be collecting data on #psychedelic use in #Headache, #Migraine, and #ClusterHeadache. However, besides the medical, psychiatric, and recreational use questions, there are also interesting experience related questions, such as preferred #music genres during psychedelic experiences, etc.

Thanks in advance for your contributions and help!!!!

#NeuroTwitter #Neurology #Neuro #MedTwitter #PsychTwitter #Psychiatry #Psychology #PTSD #anxiety #depression #Psych #Psychotherapy #Marijuana #Cannabis #MentalHealth

[Tyler Chisholm @TylerChisholm]

Today on #CollisionsYYC, learn why @SabiMind is approaching mental & public health with psychedelic therapy, including ketamine, and some impressive insights on psychedelic efficacy with President Philippe Lucas. https://t.co/WvtyDcuEEx

[PSYCSpotlight @PSYC_Spot]

.@Optimi_Health Initiates Agreement With @SabiMind For Therapeutic Supplies Of #Psilocybin & #MDMA

Clinical distribution is a major milestone in the growth of #Canada’s #psychedelics sector from the standpoints both of business operations

$OPTHF
https://t.co/79qWR2LJqN
#stocks

[Harpreet Kaur @Hkaur_p]

With my friend & colleague Philippe Lucas (@SabiMind) at @growupcanada. Come check out our panel today. $MDMA @PharmAlaBiotech

[SABI Mind @SabiMind]

SABI Mind is pleased to announce a new licensing agreement with Filament Health Corp.

This agreement will allow patients qualifying under Health Canada regulations to access psilocybin-assisted therapies at all SABI Mind Healing Centres.

[The Talent Pool @TalentPoolHub]

The Hospitality Healing Project and @SabiMind have joined forces to launch a collaborative initiative that provides #mentalhealth education, resources, and services for #yyc’s food and hospitality industry. Learn more via @_menumagazine: https://t.co/FhGJUQ24OQ

@CMHACalgary

[Psygen @psygenltd]

Join @SabiMind Thu Jun 16 from 6-7pm MDT for the preliminary results from the Canadian Psychedelic Survey (CPS), the most comprehensive assessment of national psychedelic use amongst Canadians to date co-sponsored by Psygen.

Register here: https://t.co/pCRWH9iPVq
#psychedelics

[PharmAla Biotech @PharmAlaBiotech]

Have you heard?
PharmAla has entered into a supply agreement with @SabiMind, a leading and rapidly growing psychedelic clinic. This agreement will increase access to psychedelic-assisted therapies for patients in need.

Read more below:
https://t.co/5HPaPTzSOz

$MDMA

[Microdose Psychedelic Insights @MicrodoseHQ]

$MDMA @PharmAlaBiotech has signed an agreement with @SabiMind which will allow for its GMP MDMA to be administered to patients at SABI Mind's Healing Centres.

#psychedelics #medicine #MDMA #MentalHealth @Nickkadysh
https://t.co/SpfZcQKRXB

[SABI Mind @SabiMind]

Lift & Co Expo 2022 is approaching fast.

If you’re in the Toronto area on May 14th, 2022, join Philippe Lucas for an afternoon discussion on "NEW PSYCHEDELICS DATA: The Latest Industry Analysis for Canadian Psychedelics."

Tickets are on sale now. https://t.co/JRSql4Wzpj

[Dr. Eric P. Baron @Neuralgroover]

Attention #Canadians! @MAPSCanada, @cdnpsychedelic, and @SabiMind have released The Canadian #Psychedelic Survey. I'm collaborating to collect #migraine, #cluster, and #headache data, but they need YOUR input on ALL reasons and doses used at this link: https://t.co/u4tiqqsY47
1/6